Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Empowering Pharma and Biotech Professionals: DGE Explores Strategies to Incorporate Patient Voice Across the Commercial Product Lifecycle, Philadelphia, January 25-26, 2024

Professionals working in the pharma, medical device, and biotechnology companies, are invited to attend the DGE event, Incorporate Patient Voice Across the Commercial Product Lifecycle being held in Philadelphia on January 25-26, 2024. A live-streaming option for the event is also available. The event is organized by Dynamic Global Events (“DGE”), a leading life science […]

Discovering New Golf Friends and Games Locally Has Never Been Easier Thanks to GolfLync Inc.

GolfLync, the pioneering golf social networking platform, is revolutionizing golf networking. GolfLync’s focus is on connecting like-minded players over their shared love for golf. New advanced filtering algorithms empower users to match with new players, find local friends, and discover new Virtual Golf Clubs (“VGC”) locally and while traveling. Now finding the perfect match is […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Results in Ongoing GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced additional positive interim results from its ongoing human pilot study that seeks to provide an early-stage indication of whether DehydraTECH(TM) processing could improve oral drug delivery characteristics of the GLP-1 drug semaglutide. The study, which focused on Rybelsus(R), a commercially available semaglutide […]

PaxMedica Inc. (NASDAQ: PXMD) Closes Public Offering of Approximately $7 Million and Continues Pursuing ASD Pipeline

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently reported the closing of its public offering. PaxMedica’s total gross proceeds from the offering, before deducting the placement agent’s fees and other […]

D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates Advances in Quantum Computing Through Quantum Error Mitigation and High-Coherence Fluxonium Qubits

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently shared important research results that demonstrate successful quantum error mitigation (“QEM”) in its Advantage2(TM) annealing quantum computing experimental prototype. This progress in reducing errors in quantum computers is expected to drive performance […]

Diamond Lake Minerals Inc. (DLMI) Riding Growing Sea Swell Favoring Digital Assets, Security Tokens

As market traders increasingly adopt security tokens into their investment portfolios, a new period of market evolution is unfolding and multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is developing a reputation for helping customers participate in new tech-based opportunities without having to figure out the intricacies of buying crypto and other digital assets. The […]

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Reveals Positive Drilling Results in Recent Interview

Samuel David, President and CEO of Prospera Energy (TSX.V: PEI) (OTC:s GXRFF) (FRA: OF6B), recently discussed the company’s successful drilling program in an interview on the Financial Survival Network (https://ibn.fm/44mbK). “We have drilled five horizontals and infield drilling based on geological well delineation, well control, and seismic delineation,” said Mr. David during the interview. “Therefore, […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Celebrates Canada’s Decision to Add $4.28 Million in Funding to REE Separation Tech Development

A modern-day type of “arms race” focused on computer magnet technology instead of military weaponry is leading Western governments to work with private companies on the development of their own supply chains for the magnets’ components. Strategic metals innovator Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is celebrating news that the Canadian government will add […]

Vision Marine Technologies Inc. (NASDAQ: VMAR) Is ‘One to Watch’

Vision Marine Technologies (NASDAQ: VMAR) is a global leader and innovator within the performance electric recreational boating industry. The company is engaged in designing and manufacturing electric outboard powertrain systems and related technology. It strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Building a Global Presence with Superior Delivery Technology for Wide Range of Drugs and Active Pharmaceutical Ingredients

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains committed to its mission to provide healthier delivery methods of drugs and other Active Pharmaceutical Ingredients (“APIs”). This is made possible through its patented drug delivery technology, DehydraTECH(TM), proven to enhance the performance of several categories of fat-soluble active molecules and drugs across […]

 

From Our Blog

SS Innovations International, Inc. (NASDAQ: SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach

November 6, 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is seeing increased adoption of its SSi Mantra surgical robotic platform, with CEO Dr. Sudhir Srivastava telling The Motley Fool’s interviewer Rachel Warren that the company’s commercial growth reflects a combination of technological capabilities, clinical experience and affordability (https://ibn.fm/EJk05). During the interview, Srivastava […]

Rotate your device 90° to view site.